Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia

No abstract is available for this paper.

• Publication year

  1992

• Venue

  British Journal of Haematology

• Publication date

  1992-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.1992.tb04559.xPMID 1581231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pentostatin induces durable remissions in hairy cell leukemia.

  1991cited by this paper
• Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a.

  1990cited by this paper
• Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.

  1990cited by this paper
• Treatment of Hairy Cell Leukaemia with 2'-Deoxycoformycin.

  1990cited by this paper
• Durable complete remissions after 2′‐deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alpha

  1990cited by this paper
• [Splenectomy in the treatment of hairy cell leukemia].

  1989cited by this paper
• Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.

  1989cited by this paper
• Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.

  1989cited by this paper
• Very low dose alpha-2b interferon for the treatment of hairy cell leukemia [see comments]

  1989cited by this paper
• Pentostatin in the treatment of advanced hairy cell leukemia.

  1989cited by this paper
• Very low dose alpha-2b interferon for the treatment of hairy cell leukemia.

  1989cited by this paper
• Pentostatin in hairy cell leukemia: treatment by the special exception mechanism.

  1989cited by this paper
• Recombinant interferon‐alpha‐2b treatment of hairy‐cell leukaemia: Experience with a low‐dose schedule

  1988cited by this paper
• Reversal of infection with Mycobacterium avium intracellulare by treatment with alpha-interferon in a patient with hairy cell leukemia.

  1988cited by this paper
• Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.

  1988cited by this paper
• Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group.

  1988cited by this paper
• Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).

  1987cited by this paper
• Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia.

  1987cited by this paper
• Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia.

  1987cited by this paper
• Splenectomy for hairy cell leukemia: A clinical review of 63 patients

  1986cited by this paper
• The treatment of hairy‐cell leukaemia with 2′‐deoxycoformycin

  1986cited by this paper
• Disseminated atypical mycobacterial infection in patients with hairy cell leukemia.

  1986cited by this paper
• Response to 2'-deoxycoformycin after failure of interferon-alpha in nonsplenectomized patients with hairy cell leukemia.

  1986cited by this paper
• Treatment of hairy-cell leukemia with recombinant alpha 2-interferon.

  1986cited by this paper
• Interferon is effective in hairy‐cell leukaemia

  1985cited by this paper
• Treatment of hairy cell leukemia with recombinant alpha 2 interferon.

  1985cited by this paper
• Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.

  1985cited by this paper
• Recombinant alpha-2-interferon for hairy cell leukemia.

  1985cited by this paper
• Hairy cell leukemia: clinical presentation and follow-up of 211 patients.

  1984cited by this paper
• Exact significance testing to establish treatment equivalence with ordered categorical data.

  1984cited by this paper
• Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin).

  1984cited by this paper
• Alpha interferon for induction of remission in hairy-cell leukemia.

  1984cited by this paper
• Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement.

  1983cited by this paper
• Toxicity and response criteria of the Eastern Cooperative Oncology Group

  1982cited by this paper
• Splenectomy for the treatment of hairy-cell leukemia.

  1982cited by this paper
• Splenectomy for hairy cell leukaemia.

  1981cited by this paper
• Infections in hairy cell leukemia (leukemic reticuloendotheliosis)

  1981cited by this paper
• Splenectomy in hairy cell leukemia: A retrospective multicenter analysis

  1981cited by this paper
• Splenectomy as initial therapy in twenty-six patients with leukemic reticuloendotheliosis (hairy cell leukemia).

  1979cited by this paper
• Leukemic reticuloendotheliosis (hairy cell leukemia).

  1979cited by this paper
• Infections in hairy-cell leukemia.

  1978cited by this paper
• Hairy cell leukemia: a clinical review based on 71 cases.

  1978cited by this paper
• HAIRY CELL LEUKEMIA: A REVIEW

  1978cited by this paper
• Leukemic reticuloendotheliosis

  1974cited by this paper
• Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis.

  1971cited by this paper
• Leukemic reticuloendotheliosis.

  1958cited by this paper

• Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature

  2020cites this paper
• Colorectal Cancer Immunotherapy: Options and Strategies

  2020cites this paper
• Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

  2017cites this paper
• Current Therapy and New Directions in the Treatment of Hairy Cell Leukemia: A Review.

  2016cites this paper
• The Therapy of Hairy Cell Leukemia: The State of Art

  2015cites this paper
• Current and emerging treatment options for hairy cell leukemia

  2015cites this paper
• Bone marrow and splenic histology in hairy cell leukaemia.

  2015cites this paper
• Potential breakthroughs with investigational drugs for hairy cell leukemia

  2015cites this paper
• Current Therapy and NewDirections in the Treatment of Hairy Cell Leukemia A Review

  2015cites this paper
• Hairy cell leukemia: Update on molecular profiling and therapeutic advances.

  2014cites this paper
• Hairy cell leukemia: short review, today's recommendations and outlook

  2014cites this paper
• behavior subset refractory to single-agent cladribine and with more aggressive Hairy cell leukemias with unmutated IGHV genes define the minor

  2013cites this paper
• Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias.

  2012cites this paper
• Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant*

  2012cites this paper
• Infectious complications in hairy cell leukemia

  2011cites this paper
• Modern strategies for hairy cell leukemia.

  2011cites this paper
• IFN-α cannot substitute lack of IFN-γ responsiveness in cells of an IFN-γR1 deficient patient.

  2011cites this paper
• Regulation of the Th1 immune response : the role of IL-23 and the influence of genetic variations

  2010cites this paper
• Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases

  2009cites this paper
• Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior.

  2009cites this paper
• Current Management of Hairy Cell Leukemia

  2008cites this paper
• Hairy cell leukemia

  2007cites this paper
• Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant.

  2007cites this paper
• Pentostatin: impact on outcome in hairy cell leukemia.

  2006cites this paper
• Current treatment options in hairy cell leukemia and hairy cell leukemia variant.

  2006cites this paper
• Splenectomy, interferon, and treatments of historical interest in hairy cell leukemia.

  2006cites this paper
• Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications.

  2005cites this paper
• Towards the pharmacotherapy of hairy cell leukaemia

  2004cites this paper
• Pentostatin in the treatment of hairy-cell leukemia.

  2003cites this paper
• Advances in the treatment of hairy-cell leukaemia.

  2003cites this paper
• Hairy Cell Leukemia Presenting as Localized Skeletal Involvement

  2002cites this paper
• The diagnosis and treatment of hairy-cell leukaemia.

  2002cites this paper
• Alpha/Beta Interferon Impairs the Ability of Human Macrophages To Control Growth of Mycobacterium bovis BCG

  2002cites this paper
• Hairy Cell Leukemia

  2002cites this paper
• Phase II trials of pentostatin (Nipent) in hairy cell leukemia.

  2000cites this paper
• Current Clinical Practice: Treatment of Hairy Cell Leukemia at the Close of the 20th Century

  1999cites this paper
• HAIRY‐CELL LEUKAEMIA: BIOLOGY AND MANAGEMENT

  1999cites this paper
• [Therapeutic aspects in the management of hairy cell leukemia].

  1999cites this paper
• Clinical experience with 2'-deoxycoformycin.

  1996cites this paper
• Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.

  1996cites this paper
• La leucémie à tricholeucocytes: approches thérapeutiques

  1996cites this paper
• [Hairy cell leukemia: therapeutic approaches].

  1996cites this paper
• Purine nucleoside analogues: fludarabine, pentostatin, and cladribine

  1996cites this paper
• Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.

  1995cites this paper
• Impaired interferon alpha response in hairy cell leukemia is corrected by therapy with 2-chloro-2'-deoxyadenosine: implications for susceptibility to opportunistic infections.

  1994cites this paper
• Neurotoxicity of purine analogs: a review.

  1994cites this paper
• Long term results of interferon treatment in hairy cell leukemia. Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL).

  1994cites this paper
• Purine analogs in lymphoproliferative disorders.

  1993cites this paper
• Long‐term follow‐up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration

  1993cites this paper
• New antimetabolites in the treatment of human malignancies.

  1992cites this paper